SCHEMBL2480313

SCHEMBL2480313

CC(C)=CCC=C(C)C1CCC(C)CC1O

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.37
TRPM8 Q7Z2W7 2/20 0.37
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
GAA P10253 1/20 0.31
METAP2 P50579 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2480310 1.00 TRPA1 (0.37) TRPA1TRPM8CA1CA2CA4
SCHEMBL19576454 0.78 TRPA1 (0.43) TRPA1TRPM8CA1CA2CA4
SCHEMBL8428375 0.76 TRPA1 (0.42) TRPA1TRPM8CA1CA2CA4
SCHEMBL8428377 0.76 TRPA1 (0.42) TRPA1TRPM8CA1CA2CA4
SCHEMBL2483434 0.76 GAA (0.32) GAAMETAP2
SCHEMBL2483436 0.76 GAA (0.32) GAAMETAP2
SCHEMBL7738653 0.71 TRPA1 (0.48) TRPA1TRPM8CA1CA2CA4
SCHEMBL2477284 0.70 TSHR (0.39) TRPA1TRPM8
SCHEMBL19566541 0.70 TRPA1 (0.39) TRPA1TRPM8
SCHEMBL28907747 0.69 METAP2 (0.35) TRPA1GAAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376411-B1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS TAKASAGO PERFUMERY CO LTD (JP) 2014-11-12 EP disclosed
US-8580991-B2 Aluminium complexes and use thereof as a catalyst in intramolecular ring closure reactions TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-11-12 US disclosed
US-20110319638-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-12-29 US disclosed
US-20110257412-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-10-20 US disclosed
EP-2376412-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS Takasago International Corporation (JP) 2011-10-19 EP disclosed
EP-2376411-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS Takasago International Corporation (JP) 2011-10-19 EP disclosed
WO-2010071231-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS TAKASAGO INTERNATIONAL CORPORATION (JP) 2010-06-24 WO disclosed
WO-2010071227-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS TAKASAGO INTERNATIONAL CORPORATION (JP) 2010-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257412-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS C9, NFE2L2, ALOX12 TRPA1 376/4885TRPM8 3103/4885CA1 315/4885
US-20110319638-A1 ALUMINIUM COMPLEXES AND USE THEREOF AS A CATALYST IN INTRAMOLECULAR RING CLOSURE REACTIONS LEF1, AP1M1, C9 TRPA1 884/4885TRPM8 3538/4885CA1 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.